rts logo

Positives for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) as stock gains in recent trading

Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) is 51.44% higher on its value in year-to-date trading and has touched a low of $7.80 and a high of $17.69 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TEVA stock was last observed hovering at around $16.36 in the last trading session, with the day’s loss setting it -0.55%.

Currently trading at $15.81, the stock is -5.66% and -2.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.81 million and changing -3.36% at the moment leaves the stock 26.87% off its SMA200. TEVA registered 98.62% gain for a year compared to 6-month gain of 39.54%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -4.82% loss in the last 1 month and extending the period to 3 months gives it a 11.34%, and is -3.24% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.96% over the week and 2.85% over the month.

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has around 37226 employees, a market worth around $17.91B and $16.02B in sales. Fwd P/E is 5.73. Profit margin for the company is -2.88%. Distance from 52-week low is 102.69% and -10.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.91%).

The EPS is expected to shrink by -4.13% this year.

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Top Institutional Holders

The shares outstanding are 1.13B, and float is at 1.13B with Short Float at 2.17%.

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity

The most recent transaction is an insider sale by MIGNONE ROBERTO,the company’sDirector. SEC filings show that MIGNONE ROBERTO sold 519,000 shares of the company’s common stock on Jun 18 ’24 at a price of $17.03 per share for a total of $8.84 million. Following the sale, the insider now owns 0.98 million shares.

Teva- Pharmaceutical Industries Ltd. ADR disclosed in a document filed with the SEC on May 16 ’24 that Weiss Amir (Chief Accounting Officer) sold a total of 12,635 shares of the company’s common stock. The trade occurred on May 16 ’24 and was made at $16.65 per share for $0.21 million. Following the transaction, the insider now directly holds 5179.0 shares of the TEVA stock.

Still, SEC filings show that on May 15 ’24, Weiss Amir (Chief Accounting Officer) disposed off 15,500 shares at an average price of $16.80 for $0.26 million. The insider now directly holds 17,814 shares of Teva- Pharmaceutical Industries Ltd. ADR (TEVA).

Related Posts